Cardiff Oncology, Inc. · NASDAQ:CRDF
BlackRock, Inc.'s stake in Cardiff Oncology, Inc. fell to 1.30% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc.'s stake in Cardiff Oncology, Inc. fell to 1.30%, 863,259 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 1.30%
- Shares
- 863,259
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.30% | 863,259 |
Source
Related
- Cardiff Oncology, Inc.
- BlackRock, Inc.
- Cardiff Oncology, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Apr 23, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Pace Gary W · Jul 16, 2026
- Form 4 · Mohindru Mani · Jul 16, 2026
- Form 4 · Mohindru Mani · Jun 22, 2026
- Form 4 · Pace Gary W · Jun 22, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026